Diaclone's Scientific History

Quality Products Developed on a History of Scientific Expertise

The oustanding Diaclone product quality and scientific reputation is built on cutting edge therapeutic antibody collaborations within the pharmaceutical industry. The same level of quality is the hallmark of the entire Diaclone product range maintaining our reputation as an established centre of excellence for monoclonal antibody research and development. From monoclonal antibodies through to assay development our expertise is every present ensuring consistent high product quality.

1986: Founded in collaboration with the Regional Bloodbank in Besancon to develop monoclonal antibodies for in vitro bone marrow depletion prior to autologous transplantation.

1988: First in-vivo treatment of graft versus host disease using a Diaclone Monoclonal Antibody against CD25